MigVax is developing an oral subunit vaccine for COVID-19. Humanity has never faced such a challenge - develop a vaccine within 18 months! MigVax team has combined decades of track record with successful global vaccine and pharmaceutical achievements. • Requirements Proficiency in Protein Biochemistry(hands on): o Protein expression in E coli, yeast, insect and/or mammalian cells o Protein purification – SEC, Inversed Phase, affinity (Akta) o Manufacturing process development o Protein analysis: ELISA, WB, impurities (HPLC) o Protein activity analysis: Cell-based assays development and performance, binding assays o Experience in assay qualification and validation is a great advantage o Knowledge of GMP-based documentation in an R&D environment • Experience in writing of quality documents: SOPs, protocols, research reports • Experience in the writing of the scientific part of CMC (under RA support) – big advantage • Team management experience is an advantage. • Subcontractors daily management and guidance/collaboration experience is an advantage.